Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

T. Ellingsen; Kim Hørslev-Petersen; Merete Lund Hetland; P. Junker; Jan Pødenphanth; Mikkel Østergaard; K. Stengaard-Pedersen

Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

T. Ellingsen, Kim Hørslev-Petersen, Merete Lund Hetland, P. Junker, Jan Pødenphanth, Mikkel Østergaard, K. Stengaard-Pedersen

20 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	64
Udgave nummer	10 suppl.
Sider (fra-til)	S181
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2012

Citationsformater

Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study. / Ellingsen, T.; Hørslev-Petersen, Kim; Hetland, Merete Lund et al.

I: Arthritis & Rheumatism, Bind 64, Nr. 10 suppl., 2012, s. S181.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{e96f4abb62ff48c3977ae1a7ca934aea,

title = "Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.",

author = "T. Ellingsen and Kim H{\o}rslev-Petersen and Hetland, {Merete Lund} and P. Junker and Jan P{\o}denphanth and Mikkel {\O}stergaard and K. Stengaard-Pedersen",

year = "2012",

language = "English",

volume = "64",

pages = "S181",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 suppl.",

}

TY - ABST

T1 - Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

AU - Ellingsen, T.

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, P.

AU - Pødenphanth, Jan

AU - Østergaard, Mikkel

AU - Stengaard-Pedersen, K.

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 2326-5205

VL - 64

SP - S181

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 suppl.

ER -